Peptide-Conjugated PMOs for the Treatment of Myotonic Dystrophy. (2023)

First Author: Stoodley J
Attributed to:  Preclinical Development of Peptide Oligonucleotides for Myotonic Dystrophy Type 1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/978-1-0716-2772-3_13

PubMed Identifier: 36401033

Publication URI: http://europepmc.org/abstract/MED/36401033

Type: Journal Article/Review

Volume: 2587

Parent Publication: Methods in molecular biology (Clifton, N.J.)

ISSN: 1064-3745